Literature DB >> 20832375

Correlates of depression among people with diabetes: The Translating Research Into Action for Diabetes (TRIAD) study.

Beth Waitzfelder1, Robert B Gerzoff, Andrew J Karter, Stephen Crystal, Mathew J Bair, Susan L Ettner, Arleen F Brown, Usha Subramanian, Shou-En Lu, David Marrero, William H Herman, Joseph V Selby, R Adams Dudley.   

Abstract

AIM: The broad objective of this study was to examine multiple dimensions of depression in a large, diverse population of adults with diabetes. Specific aims were to measure the association of depression with: (1) patient characteristics; (2) outcomes; and (3) diabetes-related quality of care.
METHODS: Cross-sectional analyses were performed using survey and chart data from the Translating Research Into Action for Diabetes (TRIAD) study, including 8790 adults with diabetes, enrolled in 10 managed care health plans in 7 states. Depression was measured using the Patient Health Questionnaire (PHQ-8). Patient characteristics, outcomes and quality of care were measured using validated survey items and chart data.
RESULTS: Nearly 18% of patients had major depression, with prevalence 2-3 times higher among patients with low socioeconomic status. Pain and limited mobility were strongly associated with depression, controlling for other patient characteristics. Depression was associated with slightly worse glycemic control, but not other intermediate clinical outcomes. Depressed patients received slightly fewer recommended diabetes-related processes of care.
CONCLUSIONS: In a large, diverse cohort of patients with diabetes, depression was most prevalent among patients with low socioeconomic status and those with pain, and was associated with slightly worse glycemic control and quality of care.
Copyright © 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832375      PMCID: PMC4269468          DOI: 10.1016/j.pcd.2010.07.002

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  48 in total

1.  A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Authors:  J F Wernicke; Y L Pritchett; D N D'Souza; A Waninger; P Tran; S Iyengar; J Raskin
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

2.  Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.

Authors:  Wayne Katon; Jürgen Unützer; Ming-Yu Fan; John W Williams; Michael Schoenbaum; Elizabeth H B Lin; Enid M Hunkeler
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

3.  The association between quality of care and the intensity of diabetes disease management programs.

Authors:  Carol M Mangione; Robert B Gerzoff; David F Williamson; W Neil Steers; Eve A Kerr; Arleen F Brown; Beth E Waitzfelder; David G Marrero; R Adams Dudley; Catherine Kim; William Herman; Theodore J Thompson; Monika M Safford; Joe V Selby
Journal:  Ann Intern Med       Date:  2006-07-18       Impact factor: 25.391

4.  Does diabetes double the risk of depression?

Authors:  Patrick J O'Connor; A Lauren Crain; William A Rush; Ann M Hanson; Lucy Rose Fischer; John C Kluznik
Journal:  Ann Fam Med       Date:  2009 Jul-Aug       Impact factor: 5.166

5.  Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT).

Authors:  Hillary R Bogner; Knashawn H Morales; Edward P Post; Martha L Bruce
Journal:  Diabetes Care       Date:  2007-08-23       Impact factor: 19.112

6.  Depressive symptomatology mediates the effect of socioeconomic disadvantage on HbA(1c) among rural African Americans with type 2 diabetes.

Authors:  Steven M Kogan; Gene H Brody; Yi-Fu Chen
Journal:  J Psychosom Res       Date:  2009-04-01       Impact factor: 3.006

7.  Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.

Authors:  M A Testa; D C Simonson
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

8.  Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity.

Authors:  Jeffrey S Gonzalez; Steven A Safren; Enrico Cagliero; Deborah J Wexler; Linda Delahanty; Eve Wittenberg; Mark A Blais; James B Meigs; Richard W Grant
Journal:  Diabetes Care       Date:  2007-05-29       Impact factor: 19.112

9.  The PHQ-8 as a measure of current depression in the general population.

Authors:  Kurt Kroenke; Tara W Strine; Robert L Spitzer; Janet B W Williams; Joyce T Berry; Ali H Mokdad
Journal:  J Affect Disord       Date:  2008-08-27       Impact factor: 4.839

10.  Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes.

Authors:  James E Aikens; Denise White Perkins; Bonnie Lipton; John D Piette
Journal:  Diabetes Care       Date:  2009-04-23       Impact factor: 17.152

View more
  11 in total

Review 1.  Predictors of depression symptoms in patients with diabetes in Slovakia.

Authors:  Marek Majdan; Lenka Krajcovicova; Jarmila Pekarcikova; Razvan Chereches; Monica O'Mullane
Journal:  Int J Psychiatry Med       Date:  2012       Impact factor: 1.210

2.  Low socioeconomic status is associated with increased risk for hypoglycemia in diabetes patients: the Diabetes Study of Northern California (DISTANCE).

Authors:  Seth A Berkowitz; Andrew J Karter; Courtney R Lyles; Jennifer Y Liu; Dean Schillinger; Nancy E Adler; Howard H Moffet; Urmimala Sarkar
Journal:  J Health Care Poor Underserved       Date:  2014-05

Review 3.  Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators.

Authors:  Rakesh Jain; Shailesh Jain; Charles L Raison; Vladimir Maletic
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

Review 4.  [Depression and diabetes mellitus type 2].

Authors:  M Deuschle; U Schweiger
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

5.  Differences in the clinical recognition of depression in diabetes patients: the Diabetes Study of Northern California (DISTANCE).

Authors:  Darrell L Hudson; Andrew J Karter; Alicia Fernandez; Melissa Parker; Alyce S Adams; Dean Schillinger; Howard H Moffet; Jufen Zhou; Nancy E Adler
Journal:  Am J Manag Care       Date:  2013-05       Impact factor: 2.229

6.  Depression in persons with diabetes by age and antidiabetic treatment: a cross-sectional analysis with data from the Hordaland Health Study.

Authors:  Line I Berge; Trond Riise; Grethe S Tell; Marjolein M Iversen; Truls Østbye; Anders Lund; Ann Kristin Knudsen
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

7.  Depression in diabetic patients attending University of Gondar Hospital Diabetic Clinic, Northwest Ethiopia.

Authors:  Anteneh Messele Birhanu; Fekadu Mazengia Alemu; Tesfaye Demeke Ashenafie; Shitaye Alemu Balcha; Berihun Assefa Dachew
Journal:  Diabetes Metab Syndr Obes       Date:  2016-05-11       Impact factor: 3.168

8.  Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence.

Authors:  Yuying Zhang; Rose Zw Ting; Wenying Yang; Weiping Jia; Wenhui Li; Linong Ji; Xiaohui Guo; Alice Ps Kong; Yun-Kwok Wing; Andrea Oy Luk; Norman Sartorius; Donald E Morisky; Brian Oldenburg; Jianping Weng; Juliana Cn Chan
Journal:  J Diabetes       Date:  2015-02-19       Impact factor: 4.006

9.  Measuring depression with CES-D in Chinese patients with type 2 diabetes: the validity and its comparison to PHQ-9.

Authors:  Yuying Zhang; Rose Z W Ting; Marco H B Lam; Siu-Ping Lam; Roseanne O Yeung; Hairong Nan; Risa Ozaki; Andrea O Y Luk; Alice P S Kong; Yun-Kwok Wing; Norman Sartorius; Juliana C N Chan
Journal:  BMC Psychiatry       Date:  2015-08-18       Impact factor: 3.630

10.  Prevalence of depression and its associated factors among patients with diabetes mellitus at Tirunesh-Beijing general hospital, Addis Ababa, Ethiopia.

Authors:  Nigus Alemnew Engidaw; Abate Dargie Wubetu; Elyas Admasu Basha
Journal:  BMC Public Health       Date:  2020-02-22       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.